Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research

Documenti analoghi

• Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
  di: Nathan C. Stam, et al.
  Pubblicazione: (2024)
• Research is needed to guide contingency management implementation across populations and settings
  di: Richard Rawson, et al.
  Pubblicazione: (2024)
• Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint
  di: Justin C. Strickland, et al.
  Pubblicazione: (2026)
• On the need and contents of a specific addiction recovery research agenda
  di: William L. White, et al.
  Pubblicazione: (2026)
• Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?
  di: Wayne Hall, et al.
  Pubblicazione: (2024)